BILL (NYSE: BILL) and Billtrust today announced they have launched the first live pilot to enable trusted AI agents to ...

Innoviva Specialty Therapeutics (IST), a subsidiary of Innoviva, Inc. (NASDAQ: INVA), announced today it will present data from four abstracts at IDWeek 2026, the annual meeting of the Infectious ...

For those who have memorized the knowledge of infectious disease laws, antimicrobial drugs, and pathogens, but still mix up ...

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...

Pediatricians are urging parents to prepare for RSV and other winter illnesses, emphasizing the specific risks for infants.

When verifying posts claiming that Russian authorities denied as "fake documents" the tightening of regulations following a ...

Moscow urged to disclose details of suspected outbreak amid growing scepticism of the official version of events ...

Through long-standing research, which has been supported by the National Institutes of Health, investigators at Johns Hopkins ...

An AI experiment gone wrong: at the Fortune AIQ Summit, Future Today Strategy Group CEO Amy Webb recalled accidentally sending messages to 1,000 people after a coding loop went wrong. Putin ...

Attendees are invited to join Co-Dx at Booth # H3.L38, where the Company will showcase the Co-Dx PCR platform and the Co-Dx™ ...

Analyzing data from the Global Cancer Observatory's Cancer Today (GLOBOCAN) database, the authors estimate 2.3 million new cancer cases in 2024 were associated with infection. That equates to 12 ...